Literature DB >> 8627166

CD22 associates with protein tyrosine phosphatase 1C, Syk, and phospholipase C-gamma(1) upon B cell activation.

C L Law1, S P Sidorenko, K A Chandran, Z Zhao, S H Shen, E H Fischer, E A Clark.   

Abstract

Cross-linking B cell antigen receptor (BCR) elicits early signal transduction events, including activation of protein tyrosine kinases, phosphorylation of receptor components, activation of phospholipase C-gamma (PLC-gamma), and increases in intracellular free Ca2+. In this article, we report that cross-linking the BCR led to a rapid translocation of cytosolic protein tyrosine phosphatase (PTP) 1C to the particulate fraction, where it became associated with a 140-150-kD tyrosyl-phosphorylated protein. Western blotting analysis identified this 140-150-kD protein to be CD22. The association of PTP-1C with CD22 was mediated by the NH2-terminal Src homology 2 (SH2) domain of PTP-1C. Complexes of either CD22/PTP-1C/Syk/PLC-gamma(1) could be isolated from B cells stimulated by BCR engagement or a mixture of hydrogen peroxidase and sodium orthovanadate, respectively. The binding of PLC-gamma(1) and Syk to tyrosyl-phosphorylated CD22 was mediated by the NH2-terminal SH2 domain of PLC-gamma(1) and the COOH-terminal SH2 domain of Syk, respectively. These observations suggest that tyrosyl-phosphorylated CD22 may downmodulate the activity of this complex by dephosphorylation of CD22, Syk, and/or PLC-gamma(1). Transient expression of CD22 and a null mutant of PTP-1C (PTP-1CM) in COS cells resulted in an increase in tyrosyl phosphorylation of CD22 and its interaction with PTP-1CM. By contrast, CD22 was not tyrosyl phosphorylated or associated with PTP-1CM in the presence of wild-type PTP-1C. These results suggest that tyrosyl-phosphorylated CD22 may be a substrate for PTP-1C regulates tyrosyl phosphorylation of CD22.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8627166      PMCID: PMC2192439          DOI: 10.1084/jem.183.2.547

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  56 in total

1.  Characterization of molecular components associated with surface immunoglobulin M in human B lymphocytes: presence of tyrosine and serine/threonine protein kinases.

Authors:  C Leprince; K E Draves; J A Ledbetter; R M Torres; E A Clark
Journal:  Eur J Immunol       Date:  1992-08       Impact factor: 5.532

2.  Activation of a phosphotyrosine phosphatase by tyrosine phosphorylation.

Authors:  W Vogel; R Lammers; J Huang; A Ullrich
Journal:  Science       Date:  1993-03-12       Impact factor: 47.728

3.  SH2 domains recognize specific phosphopeptide sequences.

Authors:  Z Songyang; S E Shoelson; M Chaudhuri; G Gish; T Pawson; W G Haser; F King; T Roberts; S Ratnofsky; R J Lechleider
Journal:  Cell       Date:  1993-03-12       Impact factor: 41.582

4.  CD19 of B cells as a surrogate kinase insert region to bind phosphatidylinositol 3-kinase.

Authors:  D A Tuveson; R H Carter; S P Soltoff; D T Fearon
Journal:  Science       Date:  1993-05-14       Impact factor: 47.728

5.  Association of hematopoietic cell phosphatase with c-Kit after stimulation with c-Kit ligand.

Authors:  T Yi; J N Ihle
Journal:  Mol Cell Biol       Date:  1993-06       Impact factor: 4.272

6.  Stimulation by phospholipids of a protein-tyrosine-phosphatase containing two src homology 2 domains.

Authors:  Z Zhao; S H Shen; E H Fischer
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

7.  Identification and characterization of the murine homologue of CD22, a B lymphocyte-restricted adhesion molecule.

Authors:  R M Torres; C L Law; L Santos-Argumedo; P A Kirkham; K Grabstein; R M Parkhouse; E A Clark
Journal:  J Immunol       Date:  1992-10-15       Impact factor: 5.422

8.  CD22 associates with the human surface IgM-B-cell antigen receptor complex.

Authors:  C Leprince; K E Draves; R L Geahlen; J A Ledbetter; E A Clark
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

9.  Tyrosine phosphorylation of CD22 during B cell activation.

Authors:  R J Schulte; M A Campbell; W H Fischer; B M Sefton
Journal:  Science       Date:  1992-11-06       Impact factor: 47.728

10.  Purification and characterization of a protein tyrosine phosphatase containing SH2 domains.

Authors:  Z Zhao; P Bouchard; C D Diltz; S H Shen; E H Fischer
Journal:  J Biol Chem       Date:  1993-02-05       Impact factor: 5.157

View more
  32 in total

1.  mSiglec-E, a novel mouse CD33-related siglec (sialic acid-binding immunoglobulin-like lectin) that recruits Src homology 2 (SH2)-domain-containing protein tyrosine phosphatases SHP-1 and SHP-2.

Authors:  Z Yu; M Maoui; L Wu; D Banville; S Shen
Journal:  Biochem J       Date:  2001-02-01       Impact factor: 3.857

2.  Nanoscale organization and dynamics of the siglec CD22 cooperate with the cytoskeleton in restraining BCR signalling.

Authors:  Francesca Gasparrini; Christoph Feest; Andreas Bruckbauer; Pieta K Mattila; Jennifer Müller; Lars Nitschke; Dennis Bray; Facundo D Batista
Journal:  EMBO J       Date:  2015-12-15       Impact factor: 11.598

Review 3.  Rethinking mechanisms of autoimmune pathogenesis.

Authors:  Shiv Pillai
Journal:  J Autoimmun       Date:  2013-06-25       Impact factor: 7.094

4.  Antagonism or synergism. Role of tyrosine phosphatases SHP-1 and SHP-2 in growth factor signaling.

Authors:  Ning Wang; Zhe Li; Ronghua Ding; Gerald D Frank; Takaaki Senbonmatsu; Erwin J Landon; Tadashi Inagami; Zhizhuang Joe Zhao
Journal:  J Biol Chem       Date:  2006-06-08       Impact factor: 5.157

5.  Dendritic cell-dependent inhibition of B cell proliferation requires CD22.

Authors:  Lorna Santos; Kevin E Draves; Mark Boton; Prabhjit K Grewal; Jamey D Marth; Edward A Clark
Journal:  J Immunol       Date:  2008-04-01       Impact factor: 5.422

6.  SHP-1 binds and negatively modulates the c-Kit receptor by interaction with tyrosine 569 in the c-Kit juxtamembrane domain.

Authors:  M Kozlowski; L Larose; F Lee; D M Le; R Rottapel; K A Siminovitch
Journal:  Mol Cell Biol       Date:  1998-04       Impact factor: 4.272

7.  Promising Role of Toll-Like Receptor 8 Agonist in Concert with Prostratin for Activation of Silent HIV.

Authors:  M A Rochat; E Schlaepfer; R F Speck
Journal:  J Virol       Date:  2017-01-31       Impact factor: 5.103

8.  Engagement of p75/AIRM1 or CD33 inhibits the proliferation of normal or leukemic myeloid cells.

Authors:  C Vitale; C Romagnani; M Falco; M Ponte; M Vitale; A Moretta; A Bacigalupo; L Moretta; M C Mingari
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

9.  Mechanism and function of monoclonal antibodies targeting siglec-15 for therapeutic inhibition of osteoclastic bone resorption.

Authors:  Matthew Stuible; Anna Moraitis; Annie Fortin; Stefan Saragosa; Aida Kalbakji; Mario Filion; Gilles B Tremblay
Journal:  J Biol Chem       Date:  2014-01-20       Impact factor: 5.157

10.  Rapid T cell receptor-mediated SHP-1 S591 phosphorylation regulates SHP-1 cellular localization and phosphatase activity.

Authors:  Yin Liu; Michael J Kruhlak; Jian-Jiang Hao; Stephen Shaw
Journal:  J Leukoc Biol       Date:  2007-06-15       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.